ATE183T1 - BENZOPYRAN DERIVATIVES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND PROCESSES FOR MAKING THE COMPOUNDS AND COMPOSITIONS. - Google Patents

BENZOPYRAN DERIVATIVES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND PROCESSES FOR MAKING THE COMPOUNDS AND COMPOSITIONS.

Info

Publication number
ATE183T1
ATE183T1 AT79810066T AT79810066T ATE183T1 AT E183 T1 ATE183 T1 AT E183T1 AT 79810066 T AT79810066 T AT 79810066T AT 79810066 T AT79810066 T AT 79810066T AT E183 T1 ATE183 T1 AT E183T1
Authority
AT
Austria
Prior art keywords
loweralkyl
lowercycloalkyl
hydroxy
hydroxyloweralkyl
chem
Prior art date
Application number
AT79810066T
Other languages
German (de)
Inventor
David John Blythin
Original Assignee
Scherico Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scherico Ltd. filed Critical Scherico Ltd.
Application granted granted Critical
Publication of ATE183T1 publication Critical patent/ATE183T1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/60Three or more oxygen or sulfur atoms
    • C07D239/62Barbituric acids

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

Novel compounds of the formula <CHEM> wherein each of R3 and R5 represents hydrogen or loweralkyl, n is an integer from one to four and R represents hydrogen, loweralkyl, lowercycloalkyl, lowercycloalkyl-loweralkyl, acyloxyloweralkyl, hydroxyloweralkyl, lower-alkoxyloweralkyl, nitro, halogeno, haloloweralkyl, hydroxy, loweralkoxy, acylaminoloweralkyl, aminoloweralkyl, mono- or diloweralkylaminoloweralkyl, alkanoyloxy, carboxy, loweralkoxycarbonyl, acyl, formyl, cyano or a carboxamido moiety of the structure <CHEM> wherein A is straight or branched chain alkyl with up to 12 carbon atoms, lowercycloalkyl, lowercycloalkylloweralkyl, loweralkoxyloweralkyl, hydroxyloweralkyl, fluoroloweralkyl, loweralkenyl, loweralkylthioloweralkyl, loweralkylsulfoxyloweralkyl, loweralkylsulfonylloweralkyl, thiazol, oxazolyl, thiadiazolyl, methylthiadiazolyl, furyl, pyrazolyl, tetrazolyl, methyltetrazolyl, hydroxypyrimidinyl, phenyl, pyrimidynyl-dione, or the grouping <CHEM> wherein E is a straight or branched chain or cyclic loweralkylene, x is zero or one and Q is hydroxy, loweralkoxy, amino or mono- or diloweralkylamino; or the grouping -E-R8, wherein E is as defined above and is optionally substituted by hydroxy and/or phenyl, R8 is phenyl, thiazolyl, oxazolyl, thiadiazolyl, methylthiadiazolyl, tetrazolyl, methyltetrazolyl, furyl, pyridyl, methylpyridyl or piperidinyl; and B is hydrogen, loweralkyl, lowercycloalkyl, lowercycloalkylloweralkyl, or loweralkenyl; or A and B, when taken together with the nitrogen atom to which they are attached, represent imidazolyl, morpholinyl, pyrrolidinyl, piperidinyl or piperazinyl and heterocyclic rings being optionally substituted by hydroxy, loweralkyl or hydroxyloweralkyl; and pharmaceutically acceptable salts thereof. The preparation of these compounds by five methods is described, in particular one inventive method which comprises reacting a correspondingly R-substituted salicylaldehyde and
AT79810066T 1978-07-31 1979-07-30 BENZOPYRAN DERIVATIVES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND PROCESSES FOR MAKING THE COMPOUNDS AND COMPOSITIONS. ATE183T1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US92959878A 1978-07-31 1978-07-31
EP79810066A EP0008277B1 (en) 1978-07-31 1979-07-30 Benzopyrano derivatives, pharmaceutical compositions containing them and processes for preparing the compounds and compositions

Publications (1)

Publication Number Publication Date
ATE183T1 true ATE183T1 (en) 1981-09-15

Family

ID=25458123

Family Applications (1)

Application Number Title Priority Date Filing Date
AT79810066T ATE183T1 (en) 1978-07-31 1979-07-30 BENZOPYRAN DERIVATIVES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND PROCESSES FOR MAKING THE COMPOUNDS AND COMPOSITIONS.

Country Status (4)

Country Link
EP (1) EP0008277B1 (en)
JP (1) JPS5522685A (en)
AT (1) ATE183T1 (en)
DE (1) DE2960741D1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3335472A1 (en) * 1983-09-30 1985-04-11 Gödecke AG, 1000 Berlin 5H- (1) BENZOPYRANO- (2,3, -D) PYRIMIDINE DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF AND THEIR USE IN THE FIGHT AGAINST GASTRAL AND DUODENAL MUSCLE LESIONS
DE3335473A1 (en) * 1983-09-30 1985-04-11 Gödecke AG, 1000 Berlin 4-THIOXO-BENZOPYRANO (2,3-D) PYRIMIDINE DERIVATIVES AND METHOD FOR THE PRODUCTION THEREOF

Also Published As

Publication number Publication date
EP0008277A1 (en) 1980-02-20
DE2960741D1 (en) 1981-11-26
EP0008277B1 (en) 1981-09-02
JPS5522685A (en) 1980-02-18

Similar Documents

Publication Publication Date Title
FR2687402B1 (en) NOVEL AZAINDOLES, METHODS OF PREPARATION AND MEDICAMENTS CONTAINING THEM.
HUT43584A (en) Process for production of derivatives of piperasine with antiarrythmic influence and medical compounds containing thereof
MY102082A (en) Dihydropyridine derivatives, their production and use
NO177638C (en) Analogous Process for Preparing a Therapeutically Active Spiro Compound
NZ235460A (en) Hexahydro-1,3a,8-trimethylpyrrolo(2,3-b)indol-5-yl-carbamate derivatives and pharmaceutical compositions
DK289888D0 (en) 2-SUBSTITUTED-E-CONDENSED OE1,2,4, AATRIAZOLOOE1,5-CAAPYRIMIDINES, PHARMACEUTICAL PREPARATIONS AND APPLICATIONS THEREOF
US5021413B1 (en) Analgesic thiomorpholins, their preparation, and pharmaceutical compositions containing them
GR3021865T3 (en) Compositon containing rhodacyanine dyes for treating cancer
DK570689A (en) imidazole
PT75048B (en) Process for preparing diamino isothiazole -1-oxides and -1,1-dioxides as gastric secretion inhibitors
ATE183T1 (en) BENZOPYRAN DERIVATIVES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND PROCESSES FOR MAKING THE COMPOUNDS AND COMPOSITIONS.
HUT49116A (en) Process for producing thioformamid derivatives and pharmaceutical compositions containing them as active components
HUT50160A (en) Process for production of derivatives of tiophene and medical compositions containing them as active substance
EP0180298A3 (en) Pyrimidine compounds
EP0132914A3 (en) Imidazolinone derivatives as histamine h2-antagonists
HUT34743A (en) Process for perparing amino-pyrimidinone derivatives
IL73702A0 (en) Aminopropanol derivatives of substituted 2-hydroxypropiophenones,their preparation,and therapeutic agents containing these compounds
ES8602764A1 (en) Aminothiadiazine derivatives as histamine H2-antagonists.
HU904214D0 (en) Process for producing pyrrolo(2,1-b)thiazole derivatives
NZ238238A (en) 5h,10h-pyrido(3,4-b)pyrrolo(1,2-e)(1,4,5)oxadiazepine derivatives and pharmaceutical compositions thereof having analgesic activity
EP0294828A3 (en) Mitomycin analogs, a process for preparing them and pharmaceutical compositions
HUT34316A (en) Process for producing heterocyclic hydroximidates and thiohydroximidates and their carbamate-ester derivatives
ES451655A1 (en) A procedure for the preparation of pyrimidine derivatives. (Machine-translation by Google Translate, not legally binding)
ATE28457T1 (en) (5-(2-AMINOMETHYL-IMIDAZOLE-1-YL)-1,3-DIALKYL-1H PYRAZOLE-4-YL)(ARYL)METHANONE AND PROCESS FOR THEIR PREPARATION.